S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Maribeth T. Guidotti · Study
Home
/
Author
Maribeth T. Guidotti
3 works
· latest 1998
· 1 institutions
cluster: provisional
Follow
Claim this profile
h-index
3
i10
3
Citations
159
Works here
3
93
95
98
Most cited in this library
Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines
1998 · 60 citations
1-[1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2- methoxybenzoyl]piperidin-4-yl]-4H-3,1- benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.
1995 · 55 citations
L‐368,899, a potent orally active oxytocin antagonist for potential use in preterm labor
1993 · 44 citations
Works
3 shown
Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines
Journal of Medicinal Chemistry
·
1998
·
19 authors
60
citations
1-[1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2- methoxybenzoyl]piperidin-4-yl]-4H-3,1- benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.
Journal of Medicinal Chemistry
·
1995
·
8 authors
55
citations
L‐368,899, a potent orally active oxytocin antagonist for potential use in preterm labor
Drug Development Research
·
1993
·
19 authors
44
citations